Autonomic neuropathies

Steven Vernino, Phillip Anson Low

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Many peripheral neuropathies affect autonomic fibers in isolation or in addition to somatic sensory and motor fibers. When involvement of autonomic fibers is prominent, the term autonomic neuropathy is used. The most commonly encountered autonomic neuropathies are listed in this chapter. Other neuropathies, inherited or acquired, specifically target autonomic fibers. The current understanding of the autonomic neuropathies has improved due to better understanding of the molecular basis of the inherited autonomic neuropathies, development of objective and noninvasive tests of autonomic function, and recognition of an immunological basis for many cases of subacute acquired autonomic neuropathy. The natural history of autonomic distal neuropathies due to toxins and drugs is more favorable. The brunt of the pathology is manifested at the distal ends of the longest nerve fibers. Although the cell body can be affected, its involvement is usually partial and capable of recovery. Following withdrawal of the toxin or cessation of the drug, slow recovery is expected. The natural history of positive somatic and autonomic symptomatology is complex. Recovery is typical but not invariable. Part of the incomplete recovery relates to the incompleteness of fiber regeneration. However, there can be functional alterations.

Original languageEnglish (US)
Title of host publicationNeurobiology of Disease
PublisherElsevier Inc.
Pages979-986
Number of pages8
ISBN (Print)9780120885923
DOIs
StatePublished - 2007

Fingerprint

Natural History
Peripheral Nervous System Diseases
Nerve Fibers
Pharmaceutical Preparations
Regeneration
Pathology
Cell Body

ASJC Scopus subject areas

  • Dentistry(all)
  • Medicine(all)

Cite this

Vernino, S., & Low, P. A. (2007). Autonomic neuropathies. In Neurobiology of Disease (pp. 979-986). Elsevier Inc.. https://doi.org/10.1016/B978-012088592-3/50091-8

Autonomic neuropathies. / Vernino, Steven; Low, Phillip Anson.

Neurobiology of Disease. Elsevier Inc., 2007. p. 979-986.

Research output: Chapter in Book/Report/Conference proceedingChapter

Vernino, S & Low, PA 2007, Autonomic neuropathies. in Neurobiology of Disease. Elsevier Inc., pp. 979-986. https://doi.org/10.1016/B978-012088592-3/50091-8
Vernino S, Low PA. Autonomic neuropathies. In Neurobiology of Disease. Elsevier Inc. 2007. p. 979-986 https://doi.org/10.1016/B978-012088592-3/50091-8
Vernino, Steven ; Low, Phillip Anson. / Autonomic neuropathies. Neurobiology of Disease. Elsevier Inc., 2007. pp. 979-986
@inbook{faec63e4af784ee781c47aaeca9cfb48,
title = "Autonomic neuropathies",
abstract = "Many peripheral neuropathies affect autonomic fibers in isolation or in addition to somatic sensory and motor fibers. When involvement of autonomic fibers is prominent, the term autonomic neuropathy is used. The most commonly encountered autonomic neuropathies are listed in this chapter. Other neuropathies, inherited or acquired, specifically target autonomic fibers. The current understanding of the autonomic neuropathies has improved due to better understanding of the molecular basis of the inherited autonomic neuropathies, development of objective and noninvasive tests of autonomic function, and recognition of an immunological basis for many cases of subacute acquired autonomic neuropathy. The natural history of autonomic distal neuropathies due to toxins and drugs is more favorable. The brunt of the pathology is manifested at the distal ends of the longest nerve fibers. Although the cell body can be affected, its involvement is usually partial and capable of recovery. Following withdrawal of the toxin or cessation of the drug, slow recovery is expected. The natural history of positive somatic and autonomic symptomatology is complex. Recovery is typical but not invariable. Part of the incomplete recovery relates to the incompleteness of fiber regeneration. However, there can be functional alterations.",
author = "Steven Vernino and Low, {Phillip Anson}",
year = "2007",
doi = "10.1016/B978-012088592-3/50091-8",
language = "English (US)",
isbn = "9780120885923",
pages = "979--986",
booktitle = "Neurobiology of Disease",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Autonomic neuropathies

AU - Vernino, Steven

AU - Low, Phillip Anson

PY - 2007

Y1 - 2007

N2 - Many peripheral neuropathies affect autonomic fibers in isolation or in addition to somatic sensory and motor fibers. When involvement of autonomic fibers is prominent, the term autonomic neuropathy is used. The most commonly encountered autonomic neuropathies are listed in this chapter. Other neuropathies, inherited or acquired, specifically target autonomic fibers. The current understanding of the autonomic neuropathies has improved due to better understanding of the molecular basis of the inherited autonomic neuropathies, development of objective and noninvasive tests of autonomic function, and recognition of an immunological basis for many cases of subacute acquired autonomic neuropathy. The natural history of autonomic distal neuropathies due to toxins and drugs is more favorable. The brunt of the pathology is manifested at the distal ends of the longest nerve fibers. Although the cell body can be affected, its involvement is usually partial and capable of recovery. Following withdrawal of the toxin or cessation of the drug, slow recovery is expected. The natural history of positive somatic and autonomic symptomatology is complex. Recovery is typical but not invariable. Part of the incomplete recovery relates to the incompleteness of fiber regeneration. However, there can be functional alterations.

AB - Many peripheral neuropathies affect autonomic fibers in isolation or in addition to somatic sensory and motor fibers. When involvement of autonomic fibers is prominent, the term autonomic neuropathy is used. The most commonly encountered autonomic neuropathies are listed in this chapter. Other neuropathies, inherited or acquired, specifically target autonomic fibers. The current understanding of the autonomic neuropathies has improved due to better understanding of the molecular basis of the inherited autonomic neuropathies, development of objective and noninvasive tests of autonomic function, and recognition of an immunological basis for many cases of subacute acquired autonomic neuropathy. The natural history of autonomic distal neuropathies due to toxins and drugs is more favorable. The brunt of the pathology is manifested at the distal ends of the longest nerve fibers. Although the cell body can be affected, its involvement is usually partial and capable of recovery. Following withdrawal of the toxin or cessation of the drug, slow recovery is expected. The natural history of positive somatic and autonomic symptomatology is complex. Recovery is typical but not invariable. Part of the incomplete recovery relates to the incompleteness of fiber regeneration. However, there can be functional alterations.

UR - http://www.scopus.com/inward/record.url?scp=84884081100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884081100&partnerID=8YFLogxK

U2 - 10.1016/B978-012088592-3/50091-8

DO - 10.1016/B978-012088592-3/50091-8

M3 - Chapter

AN - SCOPUS:84884081100

SN - 9780120885923

SP - 979

EP - 986

BT - Neurobiology of Disease

PB - Elsevier Inc.

ER -